7 things to know about Pfizer’s COVID-19 vaccine timeline

Pfizer CEO Albert Bourla, PhD, set out a timeline Oct. 16 for reaching crucial turning points in the drugmakers COVID-19 vaccine advancement..

Maia Anderson –
Monday, October 19th, 2020
Print|Email.

” To make sure public trust and clear up a lot of confusion, I believe it is necessary for the general public to understand our approximated timelines,” Dr. Bourla stated in an open letter..

7 things to understand about Pfizers vaccine development:.

Previously this month, Pfizers vaccine trial became the first in the U.S. to register children as young as 12.

Pfizer began its final-stage trial in July and in the very same month signed a $1.95 billion handle HHS and the U.S. Defense Department to protect up to 600 million doses of the vaccine..

© Copyright ASC COMMUNICATIONS 2020.

More posts on drug store: CVS to hire 15,000 staff members for influenza seasonWalgreens, CVS will provide complimentary COVID-19 vaccines at long-term care facilitiesFDA grants first-ever Ebola drug approval to Regeneron.

Pfizer could seek approval from the FDA by the end of November if the data reveals the vaccine can work safely.

Pfizer ought to have information on the vaccines security by the third week of November.

The updated timeline is in line with previous estimates by Dr. Bourla on when the vaccine would be authorized. Last month, he stated theres a “good possibility” Pfizer will know if a vaccine works by the end of October. In July, he approximated the vaccine could be authorized as early as December.

When the vaccine would be authorized, the upgraded timeline is in line with previous estimations by Dr. Bourla on. Last month, he said theres a “excellent possibility” Pfizer will know if a vaccine works by the end of October. In July, he approximated the vaccine might be authorized as early as December.

Dr. Bourla has actually promised that Pfizer would not be pressured politically to speed up its COVID-19 vaccine development. Last month, Pfizer launched its trial protocol to address concerns about a push by President Donald Trump for a vaccine before Election Day.

Pfizer should start seeing data from large studies suggesting whether the vaccine works by the end of October.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by clicking here.